Taylor Wessing

Taylor Wessing is an international law firm with 655 lawyers across 14 offices in 9 locations, providing legal services across multiple practice areas. The firm operates globally with multilingual capabilities spanning 21 languages, serving innovative businesses across various sectors including life sciences and healthcare.

The firm's life sciences and healthcare practice focuses on regulatory compliance, corporate transactions, intellectual property protection, and data privacy matters. Their service offerings include corporate M&A and capital markets advisory, data protection and cybersecurity counsel, employment and mobility matters, intellectual property litigation, and disputes resolution. Recent work includes advising Infinitopes on a $35 million seed financing expansion.

Taylor Wessing positions itself as counsel to "the world's most innovative people and businesses," with particular emphasis on supporting technology-enabled companies and those operating in regulated industries. The firm maintains specialized knowledge in areas including the EU AI Act, GDPR compliance, and critical infrastructure regulations.

Choose Taylor Wessing when your healthcare or life sciences organization requires sophisticated legal counsel for high-stakes transactions, complex regulatory matters, or international expansion. The firm excels in scenarios requiring coordinated multi-jurisdictional advice, particularly across European markets.

Expect white-glove legal service with deep regulatory knowledge, strategic business counsel, and access to specialized expertise across corporate law, IP protection, data compliance, and employment matters. The firm's integrated approach suits organizations managing multiple concurrent legal workstreams or preparing for significant corporate events.

Taylor Wessing's life sciences and healthcare practice addresses the unique legal needs of pharmaceutical companies, biotechnology firms, medical device manufacturers, and digital health innovators. The firm advises on regulatory compliance including EU Medical Device Regulation, clinical trial frameworks, and data protection requirements specific to health data.

Their healthcare work encompasses M&A transactions for life sciences companies, IP strategy and patent litigation for medical innovations, regulatory approval pathways, and corporate governance for healthcare organizations. The practice maintains current expertise in emerging areas including AI in healthcare regulation, digital therapeutics frameworks, and health data governance under evolving privacy regimes.

Ideal clients are venture-backed digital health companies, established pharmaceutical firms, medical device manufacturers, and life sciences organizations pursuing international growth, M&A transactions, or navigating complex regulatory compliance requirements. Organizations operating across multiple jurisdictions or preparing for significant corporate milestones benefit most from the firm's coordinated multi-practice approach.